Illumina, Inc. I1LM34.SA Stock
Illumina, Inc. Price Chart
Illumina, Inc. I1LM34.SA Financial and Trading Overview
Illumina, Inc. stock price | 118.17 BRL |
Previous Close | 196.92 BRL |
Open | 0 BRL |
Bid | 200.07 BRL x N/A |
Ask | 204.36 BRL x N/A |
Day's Range | 0 - 0 BRL |
52 Week Range | 0 - 258.57 BRL |
Volume | 0 BRL |
Avg. Volume | 12 BRL |
Market Cap | 157.52B BRL |
Beta (5Y Monthly) | 1.170422 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -8.75 BRL |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
I1LM34.SA Valuation Measures
Enterprise Value | 32.68B BRL |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 35.414036 |
Price/Book (mrq) | 4.6486154 |
Enterprise Value/Revenue | 7.346 |
Enterprise Value/EBITDA | 84.003 |
Trading Information
Illumina, Inc. Stock Price History
Beta (5Y Monthly) | 1.170422 |
52-Week Change | 0.21% |
S&P500 52-Week Change | 20.43% |
52 Week High | 258.57 BRL |
52 Week Low | 0 BRL |
50-Day Moving Average | 212.51 BRL |
200-Day Moving Average | 215.95 BRL |
I1LM34.SA Share Statistics
Avg. Volume (3 month) | 12 BRL |
Avg. Daily Volume (10-Days) | 29 BRL |
Shares Outstanding | 790.5M |
Float | 157.75M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | January 1, 2023 |
Most Recent Quarter (mrq) | April 2, 2023 |
Next Fiscal Year End | January 1, 2024 |
Profitability
Profit Margin | -100.87% |
Operating Margin (ttm) | -0.47% |
Gross Margin | 67.28% |
EBITDA Margin | 8.74% |
Management Effectiveness
Return on Assets (ttm) | -0.097% |
Return on Equity (ttm) | -51.022% |
Income Statement
Revenue (ttm) | 4.45B BRL |
Revenue Per Share (ttm) | 28.29 BRL |
Quarterly Revenue Growth (yoy) | -11.099% |
Gross Profit (ttm) | 3.15B BRL |
EBITDA | 389M BRL |
Net Income Avi to Common (ttm) | -4487000064 BRL |
Diluted EPS (ttm) | -28.08 |
Quarterly Earnings Growth (yoy) | -96.50% |
Balance Sheet
Total Cash (mrq) | 1.52B BRL |
Total Cash Per Share (mrq) | 9.6 BRL |
Total Debt (mrq) | 3.06B BRL |
Total Debt/Equity (mrq) | 45.75 BRL |
Current Ratio (mrq) | 1.422 |
Book Value Per Share (mrq) | 42.361 |
Cash Flow Statement
Operating Cash Flow (ttm) | 230M BRL |
Levered Free Cash Flow (ttm) | 448.88M BRL |
Profile of Illumina, Inc.
Country | Brazil |
State | CA |
City | San Diego |
Address | 5200 Illumina Way |
ZIP | 92122 |
Phone | 858 202 4500 |
Website | https://www.illumina.com |
Industry | Diagnostics & Research |
Sector(s) | Healthcare |
Full Time Employees | 11500 |
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Q&A For Illumina, Inc. Stock
What is a current I1LM34.SA stock price?
Illumina, Inc. I1LM34.SA stock price today per share is 118.17 BRL.
How to purchase Illumina, Inc. stock?
You can buy I1LM34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Illumina, Inc.?
The stock symbol or ticker of Illumina, Inc. is I1LM34.SA.
Which industry does the Illumina, Inc. company belong to?
The Illumina, Inc. industry is Diagnostics & Research.
How many shares does Illumina, Inc. have in circulation?
The max supply of Illumina, Inc. shares is 800.51M.
What is Illumina, Inc. Price to Earnings Ratio (PE Ratio)?
Illumina, Inc. PE Ratio is now.
What was Illumina, Inc. earnings per share over the trailing 12 months (TTM)?
Illumina, Inc. EPS is -8.75 BRL over the trailing 12 months.
Which sector does the Illumina, Inc. company belong to?
The Illumina, Inc. sector is Healthcare.